Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Name
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Accession Number
- DBCAT001630
- Description
Not Available
- Drugs
Drug Drug Description Indirubin Indirubin is under investigation in clinical trial NCT01735864 (Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment). - Drugs & Drug Targets
Drug Target Type Indirubin Cytochrome P450 1A1 target Indirubin Aryl hydrocarbon receptor target